Stock listing

BNN Stock Price, News, Filings & Events — Brain Biotech Ag

Selected listing: BNN · SWB · EUR · DE

This page tracks Brain Biotech Ag's BNN:SWB listing on SWB in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following BNN:SWB. BNN:SWB is the stock-level entry point for investors researching Brain Biotech Ag, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Brain Biotech AG, trading under the ticker BNN, is a public company based in Germany with a market capitalization of approximately €72.66 million. The company focuses on innovative biotechnological solutions, contributing to advancements in the field. As a publicly listed entity, Brain Biotech AG is committed to transparency and regulatory compliance in its operations.

BNN:SWBEURDEUpdated September 4, 2026
Brain Biotech Ag logo
Ticker
BNN:SWB
Asset type
Stock
Market cap
$67.8M
Sector
Health Technology
Industry
Biotechnology
Exchange
SWB
Currency
EUR

Brain Biotech Ag BNN:SWB stock context

This page tracks Brain Biotech Ag's BNN:SWB listing on SWB in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following BNN:SWB. BNN:SWB is the stock-level entry point for investors researching Brain Biotech Ag, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Brain Biotech AG, trading under the ticker BNN, is a public company based in Germany with a market capitalization of approximately €72.66 million. The company focuses on innovative biotechnological solutions, contributing to advancements in the field. As a publicly listed entity, Brain Biotech AG is committed to transparency and regulatory compliance in its operations.

Latest news from Brain Biotech Ag

All Brain Biotech Ag news →

Research Brain Biotech Ag

Alternate listings